These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 24120108
1. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events]. Grados D, Martínez-Morillo M, Holgado S, Erra A. Med Clin (Barc); 2014 May 20; 142(10):469-70. PubMed ID: 24120108 [No Abstract] [Full Text] [Related]
2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Abelson A. Curr Med Res Opin; 2008 Mar 20; 24(3):695-705. PubMed ID: 18226324 [Abstract] [Full Text] [Related]
3. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws. Gueiros LA, Lopes MA, Leão JC. J Oral Maxillofac Surg; 2008 Jun 20; 66(6):1319. PubMed ID: 18486809 [No Abstract] [Full Text] [Related]
5. Persistent effect of zoledronic acid in Paget's disease. Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F. Clin Exp Rheumatol; 2007 Dec 15; 25(3):464-6. PubMed ID: 17631747 [Abstract] [Full Text] [Related]
6. Zoledronic acid for Paget's disease of bone. Maricic M. Drugs Today (Barc); 2007 Dec 15; 43(12):879-85. PubMed ID: 18174973 [Abstract] [Full Text] [Related]
7. The use of zoledronic acid for Paget's disease of bone. Maricic M. Curr Osteoporos Rep; 2006 Mar 15; 4(1):40-4. PubMed ID: 16527007 [Abstract] [Full Text] [Related]
8. Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease. Watts MR, Ellims AH, Eccleston DS. Med J Aust; 2014 Feb 17; 200(3):150. PubMed ID: 24528425 [No Abstract] [Full Text] [Related]
9. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease? Krane SM. Nat Clin Pract Rheumatol; 2006 Apr 17; 2(4):186-7. PubMed ID: 16932682 [No Abstract] [Full Text] [Related]
10. [Therapy of Paget's disease]. Kurth AA. Orthopade; 2007 Feb 17; 36(2):118, 120-3. PubMed ID: 17252256 [Abstract] [Full Text] [Related]
13. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone. Keating GM, Scott LJ. Drugs; 2007 Feb 17; 67(5):793-804. PubMed ID: 17385948 [Abstract] [Full Text] [Related]
14. Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease. Polyzos SA, Anastasilakis AD, Litsas I, Efstathiadou Z, Kita M, Arsos G, Moralidis E, Papatheodorou A, Terpos E. J Bone Miner Metab; 2010 Nov 17; 28(6):706-12. PubMed ID: 20533067 [Abstract] [Full Text] [Related]
15. Images in clinical medicine. Saber tibia in Paget's disease of bone. Gonçalves MJ, Romão VC. N Engl J Med; 2014 Dec 18; 371(25):2417. PubMed ID: 25517708 [No Abstract] [Full Text] [Related]
16. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone. Reid IR, Maslowski K. Calcif Tissue Int; 2017 Jul 18; 101(1):43-49. PubMed ID: 28324123 [Abstract] [Full Text] [Related]
17. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy. Pirih FQ, Zablotsky M, Cordell K, McCauley LK. J Mich Dent Assoc; 2009 May 18; 91(5):38-43. PubMed ID: 19537656 [Abstract] [Full Text] [Related]
18. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. Whitson HE, Lobaugh B, Lyles KW. Bone; 2006 Oct 18; 39(4):954-8. PubMed ID: 16769264 [Abstract] [Full Text] [Related]